The rally in shares in Moderna Inc. jumped through news late Tuesday that the U.S. government ordered 100 million doses of its COVID-19 vaccine candidate on Wednesday as analysts waited for what the order meant for prices. Modern MRNA, + 1.94% is widely regarded as a front-runner in the race …
Read More »